Continuous ambulatory peritoneal dialysis and renal transplantation: a ten-year experience in a single center. 1992

D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
Renal Transplant Unit, Manchester Royal Infirmary, United Kingdom.

OBJECTIVE To assess whether a renal graft outcome is dependent on the modality of dialysis prior to transplantation and to assess risk of peritonitis and catheter-related problems posttransplantation. METHODS Retrospect analysis of the outcome of a first cadaveric renal transplantation from hemodialysis (HD) and CAPD patients over a ten-year period. METHODS Out of a total of 905 renal transplants over a ten-year period, 699 were first grafts; 500 of these (241 on CAPD, 259 on hemodialysis) were analyzed while the remaining (incomplete data, predialysis, pediatric) were assessed for graft and patient survival only. RESULTS Graft and patient survival cases were identical in the two groups (five-year graft survival: CAPD 67%, hemodialysis 66%; five-year patient survival: CAPD 88%, hemodialysis 87%). CAPD posttransplant was necessary in 37 patients, while 10 developed peritonitis mostly related to CAPD use and responded to appropriate therapy. Routine catheter removal posttransplant was undertaken between 8 and 12 weeks. CONCLUSIONS Excellent graft and patient survival is achieved independent of the modality of dialysis prior to transplantation. Peritoneal dialysis can be used postgrafting, but there is a risk of peritonitis, which can be successfully managed with antibiotics and catheter removal. Great care is needed in executing the dialysis and catheter care after transplantation.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D002408 Catheters, Indwelling Catheters designed to be left within an organ or passage for an extended period of time. Implantable Catheters,In-Dwelling Catheters,Catheter, In-Dwelling,Catheter, Indwelling,Catheters, In-Dwelling,In Dwelling Catheters,In-Dwelling Catheter,Indwelling Catheter,Indwelling Catheters
D004739 England A part of Great Britain within the United Kingdom.
D005260 Female Females
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
October 1985, British medical journal (Clinical research ed.),
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
January 2005, Nihon Jinzo Gakkai shi,
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
May 1980, Annals of internal medicine,
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
February 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation,
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
January 1989, Nephrologie,
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
May 1992, Nederlands tijdschrift voor geneeskunde,
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
April 1986, Scottish medical journal,
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
November 1987, The Journal of the Kentucky Medical Association,
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
April 1985, Presse medicale (Paris, France : 1983),
D O'Donoghue, and J Manos, and R Pearson, and P Scott, and A Bakran, and R Johnson, and P Dyer, and S Martin, and R Gokal
September 1989, Medicine,
Copied contents to your clipboard!